Focal cortical dysplasia type IIb (FCDIIb) is a malformation of cortical development characterized by the presence of balloon cells and dysmorphic neurons and often associated with focal epilepsy, 1 but not with progressive neurological deficits. We report a patient with slowly progressive aphasia as the predominant symptom of FCDIIb with no evidence of electrographic seizures on scalp EEG. Eight years after initial presentation, subacute worsening of her language prompted repeat MRI which revealed changes suggestive of a neoplasm. Biopsy instead revealed FCDIIb. This case exemplifies a challenging differential diagnosis and an unusual presentation of FCDIIb.
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Case report
A 32 year old right-handed woman presented with two convulsive seizures in 2004. EEG showed left temporal discharges; brain MRI was unrevealing. Neurological exam was unremarkable despite complaints of word finding difficulties. Clinically apparent seizures were controlled with antiepileptic drug (AED).
In 2008, she reported deterioration in word-finding and understanding information over the telephone. Exam revealed mild impairment of repetition. Repeat MRI remained unremarkable; EEG showed increased left temporal discharges. Magnetoencephalogram revealed discharges in the left perisylvian distribution. Word finding difficulties were considered a possible ictal phenomenon and were treated with multiple AEDs without improvement. CSF immuno-electropheresis, oligoclonal bands, lactate and pyruvate were unremarkable. Work-up for autoimmune encephalitides (Hu, Yo, Ma1, Ma2, voltage gated potassium and calcium channels, thyroglobulin, TPO, gluR3, GAD antibodies) was negative.
Dysphasic symptoms slowly progressed despite high-dose methyl-prednisolone, adjustment of AEDs, speech therapy and modified Atkins diet. Multiple EEGs showed left parietal and centro-temporal periodic discharges, but no definite ictal activity apparent on scalp EEG. In 2010, intermittent right facial jerks developed and correlated with generalized decrement and dissipation of the left temporal discharges on video-EEG. Brain PET showed hypo-metabolism in the left frontal, parietal and temporal lobes and hyper-metabolism in the left temporal caudate head. Multiple high-resolution MRIs remained unremarkable (see Fig. 1A for a representative example).
In 2012, she developed subacute deterioration of receptive language and increased facial jerks. Brain MRI revealed a ''new focal mass lesion involving the left temporal and parietal region concerning for a low-grade glial neoplasm''. EEG showed left central discharges, but no overt seizures. Repeat PET revealed increased uptake in the left lateral temporal lobe. MR spectroscopy showed elevated choline to creatine and decrease in NAA, consistent with demyelinating disease or low-grade glioma. Neuro-oncology consultant recommended brain biopsy.
Open biopsy was performed in the Advanced Multimodality Image Guided Operating (AMIGO) suite. Interictal discharges, but not ictal activity were recorded with intra-operative electrocorticography. Biopsy specimens from 3 cortical areas of maximal overlapping abnormality from MRI (Fig. 1B) , PET (Fig. 1C) , and electrocorticogram were obtained. Motor and language areas identified on pre-operative fMRI and intra-operative motor mapping were spared.
Pathological evaluation showed FCDIIb from all sampled areas, characterized by dyslamination ( Fig. 2A) , confirmed by NeuNimmunostain (not shown); pale, glassy, balloon-like cells (Fig. 2B); and enlarged bizarre, SMI-31-positive (dysplastic) neurons (Fig. 2C) . There was also extensive GFAP-positive reactive gliosis and CD163-positive perivascular microglia (not shown); there were no lymphocytic infiltrates. There was very low suspicion for neoplasia on histology, given the lack of glial cell atypia. Moreover, a MIB-1 immunostain showed only rare positive cells, and IDH1 (R132H mutation) immunostain was negative (not shown).
Her symptoms and MRI abnormalities improved post-operatively (Fig. 1D) as a possible result of AED adjustments and the effect of anesthesia. This improvement suggests that the MRI abnormalities were likely related to ongoing seizure activity. 4 Epilepsy surgery was considered but not pursued because the patient and family were no longer interested in a resection due to the presence of the lesion in eloquent cortex.
Discussion
This case demonstrates an atypical presentation and clinical course of FCDIIb which is characterized by localized regions of malformed cerebral cortex 1 and frequently associated with drug resistant focal epilepsy in both children and adults (ages <1-60 years). 2 Neurological deficits are not usually present interictally except in early onset or severe cases or if the malformation is related to known early-onset brain injury whereby cognitive deficits or delay in psychomotor development are also seen. 3 Alternative diagnoses were entertained but considered unlikely or ruled out during the course of the presentation. These included autoimmune encephalitis, adult onset LandauKleffner syndrome (but no nocturnal accentuation of discharges was present) and non-fluent/agrammatic variant of primary progressive aphasia (can appear in the third decade). Malignant transformation of a slow growing tumor causing progressive neurological deficits and seizures became the main suspected diagnosis after late MRI abnormalities appeared.
Our case demonstrates an unusual presentation of FCD in several regards. In addition to the relatively well-controlled overt seizures, slowly progressing aphasia dominated the clinical presentation. Scalp EEG and video EEG did not show overt ictal activity and were not useful in following the clinical course as there was likely an ongoing ictus in deeper areas inaccessible by surface EEG. Most importantly, our patient had unremarkable structural imaging for over 8 years followed by sudden appearance of marked signal changes on MRI suggesting malignancy and necessitating brain biopsy. However, MRI abnormalities were likely related to increased seizures, 4 even though no major change in surface EEG was noted. Awareness of this presentation of FCDIIb is of major clinical importance for timely diagnosis and treatment of such patients.
Author contributions
Dr. Forgacs along with Dr. Folkerth, Dr. Golby, Dr. Hsu and Dr. Dworetzky provided help with data collection. Dr. Forgacs and Dr. Dworetzky were instrumental in study concept, analysis, interpretation and design. Manuscript was prepared by Dr. Forgacs and was critically revised for important intellectual content by Dr. Sarkis, Dr. Bubrick and Dr. Dworetzky. Finally, Dr. Dworetzky took care of study supervision and coordination.
